AliveCor Named to Fast Company's Top 10 Most Innovative Companies in Health


Mountain View, Calif., February 13, 2017 – AliveCor, the leader in FDA-cleared mobile electrocardiogram (ECG/EKG) technology, was today named as one of the Top 10 Most Innovative Companies in Health for 2017 by Fast Company as part of the publication’s annual ranking of the world’s Most Innovative Companies. The list honors leading enterprises and rising newcomers that exemplify the best in nimble business and impactful innovation.

AliveCor’s scientifically validated machine-learning platform is setting a benchmark for the digital health industry, promoting early disease discovery, aiding in disease prevention, and giving people the information they need to be in control of their health and wellbeing. Having recorded over 12 million ECGs, the company is poised to lead the next evolution in healthcare innovation.

“This recognition as a top health innovator further fuels our commitment to put power in patients’ hands and help them take an active role in their total heart health,” said Vic Gundotra, CEO, AliveCor. “We are providing patients and doctors with an unprecedented view of risk factors for stroke and other diseases, advancing the doctor-patient connection and creating a new standard of care.”

Most Innovative Companies is one of Fast Company’s most significant and highly anticipated editorial efforts of the year. To produce the 2017 list, Fast Company reporters surveyed thousands of enterprises across the globe to identify the most notable innovations of the year and trace the impact of those initiatives on business, industry, and the larger culture.

Fast Company’s Most Innovative Companies issue (March 2017) is now available online as well as in app form via iTunes, and on newsstands beginning February 21.  


Fast Company is the world’s leading progressive business media brand, with a unique editorial focus on innovation in technology, ethical economics, leadership, and design. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, one of the U.S.’s leading media companies.


AliveCor, Inc. is pioneering the creation of FDA-cleared machine learning techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared Kardia Mobile is the most clinically validated mobile ECG solution on the market and is recommended by leading cardiologists and used by people worldwide for accurate ECG recordings. This simple to use mobile device and app-based service provides instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an ECG. AliveCor was recognized as a 2015 Tech Pioneer by the World Economic Forum and one of the 50 Smartest Companies in 2015 by the MIT Technology Review (#14). AliveCor is a privately-held company headquartered in Mountain View, Calif. For more information, please visit AliveCor and Kardia are trademarks of AliveCor, Inc., in the U.S. and other countries. For more information on where to buy Kardia Mobile please visit


Mary Wible Vertin,, 917.593.3223

Sarah Lawson,, 212.389.5461

Lauren Kido,, 415.963.4174 x 16